bpc-157 bioavailability oral vs injection animal studies Frontiers BPC-157 Peptide Injection vs Oral:

[2] However, once stores are depleted, symptoms can include fatigue, weakness, constipation, loss of appetite, and neurological changes such as numbness, tingling, balance problems, and cognitive difficulties

Is BPC-157 FDA-approved

I am determined to continue moving forward

Start at 0.51 mg and climb only if needed

Be alert to these supporting symptoms: Constant fatigue, even after good sleep Tingling or numbness in fingers and toes Poor memory or mental fog Mood swings or unexplained anxiety Muscle weakness Breathlessness or palpitations If your skin issues coincide with any of these , its a strong indicator that you should get your B12 levels tested